Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2009 Sep 22;23(5):314–318. doi: 10.1002/jcla.20341

An improved microalbumin method (µALB_2) with extended analytical measurement range evaluated on the ADVIA® chemistry systems

Pradip Datta 1, Amitava Dasgupta 2,
PMCID: PMC6649169  PMID: 19774630

Abstract

Quantitative determination of albumin (ALB) in human urine is important to assess kidney functions in a variety of diseases. Recently, Siemens released an improved Microalbumin assay (µALB_2) to measure urinary ALB on the automated, random access ADVIA 1650/1800, ADVIA 2400, and ADVIA 1200 Chemistry Systems. We evaluated analytical performances of this new method. All ADVIA Chemistry Systems use the same microalbumin reagent packs, µALB_2 calibrators, and commercial controls. The within‐run and total CVs of the improved method with two‐level BioRad Liquichek Urine Chemistry controls (∼2 and 9 mg/dl ALB) and a urine pool (∼29 mg/dl ALB) on all ADVIA Chemistry systems were <4.1 and <6.1%, respectively (40 replicates per sample). The analytical range/linearity of the method (all ADVIA systems) was from 0.3 mg/dl to theALB concentration in the highest level of calibrator (∼38–42 mg/dl). The improved method (µALB_2) on the ADVIA 1650/1800 (y) correlated well with both the Beckman DXC 800 Microalbumin and the old microalbumin method on the ADVIA 1650/1800 analyzers. The improved method showed <10% interference with 16 chemicals from acetaminophen to uric acid that may be present in urine. The improved method has a minimum of 60 days' on‐system stability on all systems with the calibration frequencies of (with/without a Reagent Container insert) 20/30 days (ADVIA1200), 50/60 days (ADVIA1650/1800), and 20/60 days (ADVIA2400). No prozone was observed with the method on any platform up to the highest ALB concentration tested in a sample (4,000 mg/dl). J. Clin. Lab. Anal. 23:314–318, 2009. © 2009 Wiley‐Liss, Inc.

Keywords: microalbumin, ADVIA analyzer, Beckman analyzer, interference

REFERENCES

  • 1. Soeters PB. Rationale for albumin infusion. Curr Opin Clin Nutr Metab Care 2009. March 30;12:258–264. [DOI] [PubMed] [Google Scholar]
  • 2. Guy M, Newall R, Borzomato J, Karla PA, Prive C. Diagnostic accuracy of the urinary albumin: creatinine ratio determined by the CLINITEK Microalbumin and DCA 2000+ for the rule out of albuminuria in chronic kidney disease. Clin Chim Acta 2009;399:54–58. [DOI] [PubMed] [Google Scholar]
  • 3. Weir MR. Microalbuminuria in type 2 diabetes: an important overlooked cardiovascular risk factor. J Clin Hypertens (Greenwich) 2004;6:134–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Yesim TE, Ugurlu S, Caglar E, et al. Investigation of microalbuminuria in nondiabetic normotensive obese women. Intern Med 2007;46:1963–1965. [DOI] [PubMed] [Google Scholar]
  • 5. McKie KT, Hanevold CD, Hernandez C, et al. Prevalence, prevention and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 2007;29:140–144. [DOI] [PubMed] [Google Scholar]
  • 6. Waldon JS, Baoku Y, Hartland AJ, et al. Urine microalbumin excretion in relation to exercise‐induced electrocardiographic myocardial infarction. Med Sci Monit 2002;8:CR 725–727. [PubMed] [Google Scholar]
  • 7. Kimmel PL, Umana WO, Bosch JP. Abnormal urinary protein excretion in HIV‐infected patients. Clin Nephrol 1993;39:17–21. [PubMed] [Google Scholar]
  • 8. Assadi FK. Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 2002;17:107–110. [DOI] [PubMed] [Google Scholar]
  • 9. Meinhardt U, Ammann RA, Fluck C, et al. Microalbuminuria in diabetes mellitus: Efficacy of a new screening method in comparison with timed overnight urine collection. J Diabetes Complications 2003;17:254–257. [DOI] [PubMed] [Google Scholar]
  • 10. Ng L, Teng LC, Ng ML, et al. Microalbuminuria measurements by two in house ELISA methods. Malays J Pathol 2000;22:73–78. [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES